fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
speaking after a four-day inquest, the family of brigid cavanagh, who died on july 20, 2016, said the western health trust should be ashamed after the 83-year-old had died in "terror".
.
sponsored by an innovative medicines canada company
. to add a comment. registration is free, and takes less than a minute.
.
.